Detalhe da pesquisa
1.
Population pharmacokinetics of peramivir in healthy volunteers and influenza patients.
Antimicrob Agents Chemother
; 59(11): 6755-62, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26282420
2.
Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.
Clin Infect Dis
; 52(6): 695-706, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21367722
3.
Pharmacokinetic assessment of peramivir in a hospitalized adult undergoing continuous venovenous hemofiltration.
Ann Pharmacother
; 45(12): e64, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22116989
4.
Response to several recent publications related to safety and efficacy of peramivir from the emergency use authorization experience.
Clin Infect Dis
; 56(1): 164, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22972863
5.
Peramivir pharmacokinetics in two critically ill adults with 2009 H1N1 influenza A concurrently receiving continuous renal replacement therapy.
Pharmacotherapy
; 30(10): 1016-20, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20874039
6.
American Society for Clinical Pharmacology and Therapeutics position statement on the public health risks of ephedra.
Clin Pharmacol Ther
; 74(5): 403-5, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14586380
7.
Peramivir clearance in continuous renal replacement therapy.
Hemodial Int
; 14(3): 339-40, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20491974